Entry |
|
Name |
Ecraprost (USAN/INN) |
Formula |
C28H48O6
|
Exact mass |
480.3451
|
Mol weight |
480.68
|
Structure |

|
Class |
Hormonal agent
DG01961 Prostaglandin derivative
DG01611 Prostaglandin E1 derivative
|
Efficacy |
Platelet aggregation inhibitor, Prostaglandin E1 receptor agonist |
Comment |
Prostaglandin derivative
Treatment of peripheral arterial occlusive disease
|
Target |
|
Interaction |
|
Structure map |
|
Brite |
Drug groups [BR:br08330]
Hormonal agent
DG01961 Prostaglandin derivative
DG01611 Prostaglandin E1 derivative
D02723 Ecraprost
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Prostaglandin
PTGER1
D02723 Ecraprost (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 34
1 C1y C 24.2969 -18.4865
2 C2y C 24.2969 -17.0860
3 C2y C 22.9649 -16.6532
4 C1x C 22.1417 -17.7863
5 C1y C 22.9649 -18.9193
6 C2b C 25.5098 -19.1868
7 C2b C 26.7228 -18.4865
8 C1c C 27.9357 -19.1868
9 C1b C 29.1486 -18.4865
10 C1b C 30.3616 -19.1868
11 C1b C 31.5745 -18.4865
12 C1b C 32.7874 -19.1868
13 C1a C 34.0004 -18.4865
14 C1b C 25.5098 -16.3857
15 C1b C 26.7228 -17.0860
16 C1b C 27.9357 -16.3857
17 C1b C 29.1486 -17.0860
18 C1b C 30.3616 -16.3857
19 C1b C 31.5745 -17.0860
20 C7a C 32.7874 -16.3857
21 O7a O 34.0004 -17.0860
22 C1b C 35.2133 -16.3857
23 C1b C 36.4263 -17.0860
24 O7a O 22.5359 -15.3330
25 C7a C 21.1763 -15.0440
26 O6a O 20.2202 -16.1064
27 C1b C 20.7437 -13.7135
28 C1b C 19.3586 -13.4192
29 C1a C 18.9296 -12.1008
30 O1a O 22.5359 -20.2395
31 O1a O 27.9357 -20.5874
32 O6a O 32.7874 -14.9852
33 C1b C 37.6248 -16.3857
34 C1a C 38.8378 -17.0860
BOND 34
1 1 2 1
2 2 3 2
3 3 4 1
4 4 5 1
5 1 5 1
6 1 6 1 #Up
7 6 7 2
8 7 8 1
9 8 9 1
10 9 10 1
11 10 11 1
12 11 12 1
13 12 13 1
14 2 14 1
15 14 15 1
16 15 16 1
17 16 17 1
18 17 18 1
19 18 19 1
20 19 20 1
21 20 21 1
22 21 22 1
23 22 23 1
24 3 24 1
25 24 25 1
26 25 26 2
27 25 27 1
28 27 28 1
29 28 29 1
30 5 30 1 #Down
31 8 31 1 #Down
32 20 32 2
33 23 33 1
34 33 34 1
|